Vigorous Premalignancy-specific Effector T Cell Response in the Bone Marrow of Patients with Monoclonal Gammopathy

Most approaches targeting the immune system against tumors have focused on patients with established tumors. However, whether the immune system can recognize preneoplastic stages of human cancer is not known. Here we show that patients with preneoplastic gammopathy mount a vigorous T cell response t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhodapkar, Madhav V., Krasovsky, Joseph, Osman, Keren, Geller, Matthew D.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2003
Materias:
Brief Definitive Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194131/
https://www.ncbi.nlm.nih.gov/pubmed/14638846
http://dx.doi.org/10.1084/jem.20031030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194131/
https://www.ncbi.nlm.nih.gov/pubmed/14638846
http://dx.doi.org/10.1084/jem.20031030

Ejemplares similares